Precision Lung Cancer Survivorship Care Intervention

Summary

The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors engage with care. The project involves a two-group parallel randomized clinical trial comparing the impact of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program (KLCLCSC) among lung cancer survivors (N=300) against an enhanced usual care condition (bibliotherapy+assessment) on quality of life outcomes.

Conditions

• Lung Cancer
• Pulmonary Neoplasm
• Neoplasms, Lung
• Neoplasms, Pulmonary
• Neoplasm, Pulmonary
• Cancer, Lung
• Cancers, Lung
• Pulmonary Cancer
• Cancer, Pulmonary
• Cancers, Pulmonary
• Pulmonary Cancers
• Cancer of the Lung
• Cancer of Lung
• Pulmonary Neoplasms
• Lung Cancers

Interventions

BEHAVIORAL

Kentucky LEADS Collaborative Lung Cancer Survivorship Care Program

KLCLCSC is a survivor or survivor plus caregiver-focused psychosocial and behavioral intervention designed to engage lung cancer survivors and improve lung cancer outcomes.

BEHAVIORAL

Enhanced Usual Care

EUC involves a combination of the standard of care plus a bibliotherapy intervention and assessment.

Sponsors & Collaborators

• University of Louisville

  collaborator OTHER

• G02 for Lung Cancer

  collaborator UNKNOWN

• National Cancer Institute (NCI)

  collaborator NIH

• Jerod L Stapleton, PhD

  lead OTHER

Principal Investigators

• Jamie L Studts, PhD · University of Colorado School of Medicine

• Jerod L Stapleton, PhD · University of Kentucky

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-08-16

Primary Completion

2027-07-01

Completion

2028-03-31

Countries

• United States

Study Locations